Your browser doesn't support javascript.
loading
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study.
Alderuccio, Juan P; Ai, Weiyun Z; Radford, John; Solh, Melhem; Ardeshna, Kirit M; Lunning, Matthew A; Hess, Brian T; Zinzani, Pier L; Stathis, Anastasios; Carlo-Stella, Carmelo; Hamadani, Mehdi; Kahl, Brad S; Ungar, David; Kilavuz, Turk; Yu, Eric; Qin, Yajuan; Caimi, Paolo F.
Afiliación
  • Alderuccio JP; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL.
  • Ai WZ; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.
  • Radford J; The Christie National Health Service (NHS) Foundation Trust, Manchester Cancer Research Centre and Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Solh M; Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA.
  • Ardeshna KM; Department of Haematology, University College of London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Lunning MA; Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE.
  • Hess BT; Hollings Medical Cancer Center, Medical University of South Carolina, Charleston, SC.
  • Zinzani PL; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli" and.
  • Stathis A; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Carlo-Stella C; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Hamadani M; Humanitas University and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milano, Italy.
  • Kahl BS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Ungar D; Division of Oncology, Washington University, St Louis, MO.
  • Kilavuz T; Clinical Development, ADC Therapeutics America, Murray Hill, NJ; and.
  • Yu E; Clinical Development, ADC Therapeutics America, Murray Hill, NJ; and.
  • Qin Y; Clinical Development, ADC Therapeutics America, Murray Hill, NJ; and.
  • Caimi PF; Clinical Development, ADC Therapeutics America, Murray Hill, NJ; and.
Blood Adv ; 6(16): 4736-4739, 2022 08 23.
Article en En | MEDLINE | ID: mdl-35790100
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Benzodiazepinas / Linfoma de Células B Grandes Difuso / Anticuerpos Monoclonales Humanizados / Recurrencia Local de Neoplasia Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Benzodiazepinas / Linfoma de Células B Grandes Difuso / Anticuerpos Monoclonales Humanizados / Recurrencia Local de Neoplasia Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article